![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Induction Healthcare Group Plc | LSE:INHC | London | Ordinary Share | GB00BJ0M3545 | ORD 0.5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 10.00 | 9.00 | 11.00 | 10.00 | 10.00 | 10.00 | 0.00 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Business Services, Nec | 12.88M | -17.38M | -0.1882 | -0.53 | 9.24M |
TIDMINHC
RNS Number : 5935G
Induction Healthcare Group PLC
30 March 2022
30 March 2022
Induction Healthcare Group PLC
("Induction", the "Company", or the "Group")
AIM Rule 17 Schedule 2(g) Update
Induction (AIM: INHC), a leading virtual care platform driving digital transformation of healthcare systems worldwide, announces the following information relating to directors' disclosure under Schedule Two, paragraph (g) of the AIM Rules for Companies:
Chris Spencer, non-executive Chairman, has been a director of a private company, Acea Health Limited, since 2 April 2018. On 29 March 2022, Acea Health Limited entered into creditors voluntary liquidation.
ENQUIRIES
Induction Via Walbrook PR Ltd: induction@walbrookpr.com James Balmain, Chief Executive Officer Guy Mitchell, Chief Financial Officer Singer Capital Markets (Nominated Adviser and Broker) +44 (0)20 7496 3000 Philip Davies / Kailey Aliyar Walbrook PR Ltd induction@walbrookpr.com Paul McManus / Stephanie Cuthbert Mob: +44(0)7980 541 893 / +44 (0)7796 794 663 About Induction - www.inductionhealthcare.com
Induction (AIM: INHC) Induction delivers a suite of software solutions through a single integrated platform that transforms care delivery. Our system-wide applications help healthcare providers and administrators to deliver care at any stage remotely as well as face-to-face - enabling a more flexible, efficient and positive experience for the communities they serve . Purpose built for integration with leading Electronic Medical Record (EMR) platforms, our products offer immediate stand-alone value that becomes even greater when integrated with pre-existing systems.
Used at scale by national and regional healthcare systems, as well non-health government services, our applications are relied upon by hundreds of thousands of clinicians and millions of patients across almost every hospital in the British Isles.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
MSCBKKBQCBKKCNN
(END) Dow Jones Newswires
March 30, 2022 06:00 ET (10:00 GMT)
1 Year Induction Healthcare Chart |
1 Month Induction Healthcare Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions